Stockscreener 앱 받기
1.19
4.80%
-0.06
시간 외 거래:
1.21
0.02
+1.68%
전일 마감가:
$1.25
열려 있는:
$1.28
하루 거래량:
261.84K
Relative Volume:
0.24
시가총액:
$15.72M
수익:
-
순이익/손실:
$-7.51M
주가수익비율:
-0.9015
EPS:
-1.32
순현금흐름:
$-8.02M
1주 성능:
-8.81%
1개월 성능:
-8.46%
6개월 성능:
+2.59%
1년 성능:
+90.10%
1일 변동 폭
$1.18
$1.2836
1주일 범위
$1.18
$1.4032
52주 변동 폭
$0.585
$3.80
Hoth Therapeutics Inc Stock (HOTH) Company Profile
명칭
Hoth Therapeutics Inc
전화
(646)756-2997
주소
1177 AVENUE OF THE AMERICAS, NEW YORK, NY
HOTH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HOTH
Hoth Therapeutics Inc
|
1.19 | 17.44M | 0 | -7.51M | -8.02M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Hoth Therapeutics Inc Stock (HOTH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-10-15 | 개시 | The Benchmark Company | Speculative Buy |
Hoth Therapeutics Inc 주식(HOTH)의 최신 뉴스
Using Bollinger Bands to evaluate Hoth Therapeutics Inc.Free Safe Entry Stock Watch Suggestions - Newser
Hoth Therapeutics Inc. stock trend outlook and recovery pathROI Focused Setup Screener With Exit Markers - Newser
What momentum shifts mean for Hoth Therapeutics Inc.Free Community Entry Consensus Trade Ideas - Newser
How to integrate Hoth Therapeutics Inc. into portfolio analysis toolsFree Entry and Exit Strategy Optimizer Tool - Newser
Why Hoth Therapeutics Inc. stock attracts strong analyst attentionDaily Technical Forecast for Quick Gains - Newser
Relative strength of Hoth Therapeutics Inc. in sector analysisFree Daily Chart Pattern Stock Forecast - Newser
Reversal indicators forming on Hoth Therapeutics Inc. stockDaily Pick Forecast with Entry Zones - Newser
Hoth Therapeutics Holds Annual Shareholder Meeting - MSN
When is Hoth Therapeutics Inc. stock expected to show significant growthBreakthrough stock performance - Jammu Links News
How strong is Hoth Therapeutics Inc. company’s balance sheetOverwhelming profit margins - Jammu Links News
Is Hoth Therapeutics Inc. a good long term investmentStay informed with expert market forecasts - Jammu Links News
What institutional investors are buying Hoth Therapeutics Inc. stockInvest smarter with comprehensive market analysis - Jammu Links News
Hoth Therapeutics Inc. Stock Analysis and ForecastBuild wealth steadily with proven methods - Jammu Links News
Does Hoth Therapeutics Inc. stock perform well during market downturnsPhenomenal wealth increase - Jammu Links News
What catalysts could drive Hoth Therapeutics Inc. stock higher in 2025Breakthrough stock performance - Jammu Links News
What is the risk reward ratio of investing in Hoth Therapeutics Inc. stockBuild wealth faster with professional insights - Jammu Links News
Why is Hoth Therapeutics Inc. stock attracting strong analyst attentionInvest smarter with actionable market insights - Jammu Links News
How many analysts rate Hoth Therapeutics Inc. as a “Buy”Earnings Report Growth Plan For Smart Trading - Jammu Links News
Hoth Therapeutics (HOTH) Expected to Announce Quarterly Earnings on Friday - Defense World
Hoth Therapeutics Regains Nasdaq ComplianceClears Key Listing Hurdle, Reaffirms Path Toward Growth - 富途牛牛
What are the latest earnings results for Hoth Therapeutics Inc.Wealth Building Picks That Work - Jammu Links News
What makes Hoth Therapeutics Inc. stock price move sharplyBest Dividend Data Feed To Watch Now - Jammu Links News
Is a relief rally coming for Hoth Therapeutics Inc. holdersWeekly Return Plan for Conservative Traders - Newser
Hoth Therapeutics Engages ICON to Expand Clinical Trial for HT-001 - Contract Pharma
Hoth Therapeutics Inc. Flashes Rebound Signal in Oversold ConditionInvestment Strategy Designed for Capital Protection - metal.it
Hoth Therapeutics to expand phase II trial of HT-001 to EU countries - Investing.com
Cancer Treatment Breakthrough: Hoth Therapeutics Takes Phase II Trial Global with Major EU Expansion - Stock Titan
What is the dividend policy of Hoth Therapeutics Inc. stockDaily Trading Forecasts From AI Tools - Jammu Links News
Published on: 2025-07-28 20:31:38 - metal.it
Hoth Therapeutics’ (HOTH) Buy Rating Reiterated at D. Boral Capital - Defense World
What analysts say about Hoth Therapeutics Inc. stockFree Wealth Management Insights - Autocar Professional
What drives Hoth Therapeutics Inc. stock priceFree Trading Strategy Suggestions - Autocar Professional
Traumatic Brain Injury Clinical, Companies, Therapeutic - openPR.com
Hoth Therapeutics Inc (HOTH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):